P. Roy, D. Banik, F. Chowdhury, and M. A. Bakar Siddique, “Magnitude of Survival Benefit Associated With Tyrosine Kinase Inhibitors in Advanced Thyroid Carcinoma: A Systematic Review and Meta-Analysis Incorporating Updated Long-Term Evidence From SELECT (Lenvatinib) and COSMIC-311 (Cabozantinib) Trials”, World J Oncol, vol. 17, no. 5, pp. 599–613, Jan. 2026, doi: 10.14740/wjon2842.